# AbbVie Inc. (ABBV)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ABBV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 31.99B | $ 4.31B | $ 7.27B | $ 70.82B | $ -5.94B |
| 2025 | $ 62.62B | $ 4.33B | $ 19.15B | $ 68.87B | $ -3.27B |
| 2024 | $ 59.21B | $ 4.50B | $ 18.74B | $ 67.84B | $ 3.33B |
| 2023 | $ 58.73B | $ 5.26B | $ 23.85B | $ 60.12B | $ 10.36B |
| 2022 | $ 64.85B | $ 13.22B | $ 27.09B | $ 64.19B | $ 17.25B |
| 2021 | $ 66.80B | $ 13.72B | $ 26.14B | $ 77.58B | $ 15.41B |
| 2020 | $ 58.35B | $ 5.88B | $ 21.39B | $ 87.06B | $ 13.08B |
| 2019 | $ 42.94B | $ 10.17B | $ 16.49B | $ 67.09B | $ -8.17B |
| 2018 | $ 43.26B | $ 7.51B | $ 16.89B | $ 40.31B | $ -8.45B |
| 2017 | $ 38.01B | $ 7.15B | $ 12.70B | $ 37.37B | $ 5.10B |
| 2016 | $ 35.27B | $ 8.19B | $ 9.03B | $ 36.84B | $ 4.64B |
| 2015 | $ 32.10B | $ 7.22B | $ 9.83B | $ 31.67B | $ 3.95B |
| 2014 | $ 28.20B | $ 2.51B | $ 4.15B | $ 14.98B | $ 1.74B |
| 2013 | $ 26.72B | $ 5.87B | $ 8.21B | $ 14.72B | $ 4.49B |
| 2012 | $ 26.54B | $ 7.62B | $ 8.68B | $ 15.67B | $ 3.36B |
| 2011 | $ 25.63B | $ 5.04B | $ 8.66B | $ 48.00M | $ 11.93B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -11.93 |
| Liabilities / Eq | -23.76 |
| Current Ratio | 0.81 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 8.83 |
| Gross Debt / FCF | 3.66 |

## Other views

- [Metrics](https://sponda.capital/en/ABBV.md)
- [Charts](https://sponda.capital/en/ABBV/charts.md)
- [Compare](https://sponda.capital/en/ABBV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.